Reuters logo
BRIEF-Sarepta, Genethon announce research collaboration for DMD treatment
2017年6月21日 / 上午11点22分 / 5 个月前

BRIEF-Sarepta, Genethon announce research collaboration for DMD treatment

June 21 (Reuters) - Sarepta Therapeutics Inc:

* Sarepta Therapeutics and Genethon announce a gene therapy research collaboration for the treatment of Duchenne Muscular Dystrophy

* Sarepta Therapeutics Inc - financial terms of collaboration have not been disclosed

* Sarepta Therapeutics Inc - Sarepta has option to co-develop Genethon’s micro-dystrophin program, which includes exclusive U.S. commercial rights

* Sarepta Therapeutics Inc - under terms of collaboration, Genethon will be responsible for early development work Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below